Exploring the Relationship Between Diet, Lifestyle and Gut Microbiome in Colorectal Cancer Development: A Recent Update

References

• Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, Lim YC, Kibria KMK, Mohiuddin AKM, Ming LC, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14(7):1732–56. 10.3390/cancers14071732
   PubMed Web of Science ®Google Scholar
• Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174. 10.1016/j.tranon.2021.101174
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103. 10.5114/pg.2018.81072
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–32. 10.1038/s41575-019-0189-8
   PubMed Web of Science ®Google Scholar
• Mannucci A, Zuppardo RA, Rosati R, Leo M, Di Perea J, Cavestro GM. Colorectal cancer screening from 45 years of age: thesis, antithesis and synthesis. World J Gastroenterol. 2019;25(21):2565–80. 10.3748/wjg.v25.i21.2565
   PubMed Web of Science ®Google Scholar
• Constantinou V, Constantinou C. Focusing on colorectal cancer in young adults (Review). Mol Clin Oncol. 2024;20(1):8. 10.3892/mco.2023.2706
   Web of Science ®Google Scholar
• Drewes JL, Housseau F, Sears CL. Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br J Cancer. 2016;115(3):273–80. 10.1038/bjc.2016.189
   Web of Science ®Google Scholar
• Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.
   PubMed Web of Science ®Google Scholar
• Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body. Protein Cell. 2010;1(8):718–25. 10.1007/s13238-010-0093-z
   PubMed Web of Science ®Google Scholar
• Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210–5. 10.1038/nature25973
   PubMed Web of Science ®Google Scholar
• Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351):327–36. 10.1038/nature10213
   PubMed Web of Science ®Google Scholar
• Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16(7):1024–33. 10.1111/cmi.12308
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–20. 10.1126/science.1104816
   PubMed Web of Science ®Google Scholar
• Ivanov II, Frutos RdL, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4(4):337–49. 10.1016/j.chom.2008.09.009
   PubMed Web of Science ®Google Scholar
• Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc. 2012;287(3):701–30. 10.1111/j.1469-185X.2012.00218.x
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–15. 10.1016/j.chom.2013.07.007
   PubMed Web of Science ®Google Scholar
• Leung A, Tsoi H, Yu J. Fusobacterium and Escherichia : models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert Rev Gastroenterol Hepatol. 2015;9(5):651–7. 10.1586/17474124.2015.1001745
   PubMed Web of Science ®Google Scholar
• Bogaert D, Keijser B, Huse S, Rossen J, Veenhoven R, van Gils E, Bruin J, Montijn R, Bonten M, Sanders E, et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One. 2011;6(2):e17035. 10.1371/journal.pone.0017035
   PubMed Web of Science ®Google Scholar
• Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326(5960):1694–7. 10.1126/science.1177486
   PubMed Web of Science ®Google Scholar
• Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001;48(2):198–205. 10.1136/gut.48.2.198
   PubMed Web of Science ®Google Scholar
• Erwin G, Zoetendal ADLA. The host genotype affects the bacterial community in the human gastronintestinal tract. Microb Ecol Health Dis. 2001;13(3):129–34.
   Google Scholar
• Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet J-P, Ugarte E, Muñoz-Tamayo R, Paslier DLE, Nalin R, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009;11(10):2574–84.
   PubMed Web of Science ®Google Scholar
• Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe. 2008;3(6):417–27. 10.1016/j.chom.2008.05.001
   PubMed Web of Science ®Google Scholar
• Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439. 10.1126/science.1237439
   PubMed Web of Science ®Google Scholar
• Walter J, Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol. 2011;65(1):411–29. 10.1146/annurev-micro-090110-102830
   PubMedGoogle Scholar
• Corr SC, Hill C, Gahan CGM. Advances in food and nutrition research. Elsevier, San Diego, US. 2009; 56:. p.1–15. https://doi.org/10.1016/S1043-4526(08)00601-3
   Google Scholar
• Sun J, Kato I. Gut microbiota, inflammation and colorectal cancer. Genes Dis. 2016;3(2):130–43. 10.1016/j.gendis.2016.03.004
   PubMed Web of Science ®Google Scholar
• Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2002;16(6):933–43. 10.1053/bega.2002.0354
   PubMed Web of Science ®Google Scholar
• Sartor RB. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology. 2010;139(6):1816–9. 10.1053/j.gastro.2010.10.036
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195–206. 10.1016/j.chom.2013.07.012
   PubMed Web of Science ®Google Scholar
• Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology. 2004;127(1):80–93. 10.1053/j.gastro.2004.03.054
   PubMed Web of Science ®Google Scholar
• Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124(2):392–400. 10.1053/gast.2003.50047
   PubMed Web of Science ®Google Scholar
• Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006;12(8):782–6. 10.1111/j.1469-0691.2006.01494.x
   PubMed Web of Science ®Google Scholar
• Housseau F, Sears CL. Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis. Cell Cycle. 2010;9(1):3–5. 10.4161/cc.9.1.10352
   PubMed Web of Science ®Google Scholar
• Abdulamir AS, Hafidh RR, Bakar FA. The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 2011;30(1):11. 10.1186/1756-9966-30-11
   PubMed Web of Science ®Google Scholar
• Hermsen JL, Schurr MJ, Kudsk KA, Faucher LD. Phenotyping Clostridium septicum infection: a surgeon’s infectious disease. J Surg Res. 2008;148(1):67–76. 10.1016/j.jss.2008.02.027
   PubMed Web of Science ®Google Scholar
• Mirza NN, McCloud JM, Cheetham MJ. Clostridium septicum sepsis and colorectal cancer - a reminder. World J Surg Oncol. 2009;7:73. 10.1186/1477-7819-7-73
   PubMed Web of Science ®Google Scholar
• Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol. 2008;23(8 Pt 1):1298–303. 10.1111/j.1440-1746.2008.05490.x
   PubMed Web of Science ®Google Scholar
• Wang X, Yang Y, Moore DR, Nimmo SL, Lightfoot SA, Huycke MM. 4-Hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis–infected macrophages. Gastroenterology. 2012;142(3):543–51.e7. 10.1053/j.gastro.2011.11.020
   Web of Science ®Google Scholar
• Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu G, Ng SC, Chan AWH, Chan FKL, Sung JJY, Yu J, et al. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in Mice. Gastroenterology. 2017;152(6):1419–33.e5. 10.1053/j.gastro.2017.01.009
   PubMed Web of Science ®Google Scholar
• Long X, Wong CC, Tong L, Chu ESH, Ho Szeto C, Go MYY, Coker OO, Chan AWH, Chan FKL, Sung JJY, et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol. 2019;4(12):2319–30. 10.1038/s41564-019-0541-3
   PubMed Web of Science ®Google Scholar
• Dai Z, Coker OO, Nakatsu G, Wu WKK, Zhao L, Chen Z, Chan FKL, Kristiansen K, Sung JJY, Wong SH, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018;6(1):70. 10.1186/s40168-018-0451-2
   PubMed Web of Science ®Google Scholar
• Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679–89. 10.1038/s41591-019-0406-6
   PubMed Web of Science ®Google Scholar
• Sheng Q, Du H, Cheng X, Cheng X, Tang Y, Pan L, Wang Q, Lin J. Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites. Oncol Lett. 2019;18(5):4834–44. Sep 10; 10.3892/ol.2019.10841
   Web of Science ®Google Scholar
• Mizutani S, Yamada T, Yachida S. Significance of the gut microbiome in multistep colorectal carcinogenesis. Cancer Sci. 2020;111(3):766–73. 10.1111/cas.14298
   Web of Science ®Google Scholar
• O’Keefe SJD, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, Posma JM, Kinross J, Wahl E, Ruder E, et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 2015;6:6342. 10.1038/ncomms7342
   PubMed Web of Science ®Google Scholar
• Song M, Chan AT. Environmental factors, gut microbiota, and colorectal cancer prevention. Clin Gastroenterol Hepatol. 2019;17(2):275–89. 10.1016/j.cgh.2018.07.012
   PubMed Web of Science ®Google Scholar
• Royston KJ, Adedokun B, Olopade OI. Race, the microbiome and colorectal cancer. World J Gastrointest Oncol. 2019;11(10):773–87.
   Web of Science ®Google Scholar
• Schroeder BO. Fight them or feed them: how the intestinal mucus layer manages the gut microbiota. Gastroenterol Rep (Oxf). 2019;7(1):3–12. 10.1093/gastro/goy052
   PubMed Web of Science ®Google Scholar
• Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339–53.e21. 10.1016/j.cell.2016.10.043
   PubMed Web of Science ®Google Scholar
• Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum acts as a pro-carcinogenic bacterium in colorectal cancer: from association to causality. Front Cell Dev Biol. 2021;9:710165. 10.3389/fcell.2021.710165
   Web of Science ®Google Scholar
• Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25(6):968–76. 10.1038/s41591-019-0458-7
   PubMed Web of Science ®Google Scholar
• Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292–8. 10.1101/gr.126573.111
   PubMed Web of Science ®Google Scholar
• Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, Gao R, Liu M, Yin M, Pan C, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21. Gastroenterology. 2017;152(4):851–66.e24. 10.1053/j.gastro.2016.11.018
   PubMed Web of Science ®Google Scholar
• Matijašić BB, Obermajer T, Lipoglavšek L, Grabnar I, Avguštin G, Rogelj I. Association of dietary type with fecal microbiota in vegetarians and omnivores in Slovenia. Eur J Nutr. 2014;53(4):1051–64. 10.1007/s00394-013-0607-6
   PubMed Web of Science ®Google Scholar
• Ruengsomwong S, La-Ongkham O, Jiang J, Wannissorn B, Nakayama J, Nitisinprasert S. Microbial community of healthy thai vegetarians and non-vegetarians, their core gut microbiota, and pathogen risk. J Microbiol Biotechnol. 2016;26(10):1723–35.
   Web of Science ®Google Scholar
• Zimmer J, Lange B, Frick J-S, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr. 2012;66(1):53–60. 10.1038/ejcn.2011.141
   PubMed Web of Science ®Google Scholar
• Rinninella E, Cintoni M, Raoul P, Lopetuso LR, Scaldaferri F, Pulcini G, Miggiano GAD, Gasbarrini A, Mele MC. Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients. 2019;11(10):2393–415. 10.3390/nu11102393
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Red Meat and Processed Meat. Lyon (FR): International Agency for Research on Cancer; 2018.
   Google Scholar
• Sasso A, Latella G. Role of heme iron in the association between red meat consumption and colorectal cancer. Nutr Cancer. 2018;70(8):1173–83. 10.1080/01635581.2018.1521441
   PubMed Web of Science ®Google Scholar
• Ijssennagger N, Belzer C, Hooiveld GJ, Dekker J, van Mil SWC, Müller M, Kleerebezem M, van der Meer R. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A. 2015;112(32):10038–43. 10.1073/pnas.1507645112
   PubMed Web of Science ®Google Scholar
• Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244–60.e16. 10.1053/j.gastro.2014.12.035
   PubMed Web of Science ®Google Scholar
• Teigen LM, Geng Z, Sadowsky MJ, Vaughn BP, Hamilton MJ, Khoruts A. Dietary factors in sulfur metabolism and pathogenesis of ulcerative colitis. Nutrients. 2019;11(4):931–50. 10.3390/nu11040931
   Web of Science ®Google Scholar
• Yao CK, Sarbagili-Shabat C. Gaseous metabolites as therapeutic targets in ulcerative colitis. World J Gastroenterol. 2023;29(4):682–91. 10.3748/wjg.v29.i4.682
   PubMed Web of Science ®Google Scholar
• Yazici C, Wolf PG, Kim H, Cross T-WL, Vermillion K, Carroll T, Augustus GJ, Mutlu E, Tussing-Humphreys L, Braunschweig C, et al. Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut. 2017;66(11):1983–94. 10.1136/gutjnl-2016-313321
   PubMed Web of Science ®Google Scholar
• Liu X, Tan F, Cui M, Li D, Yao P. Effects of red meat diet on gut microbiota in mice. Food Sci Technol. 2022;42. 10.1590/fst.28321
   Web of Science ®Google Scholar
• Alexander DD, Cushing CA. Red meat and colorectal cancer: a critical summary of prospective epidemiologic studies. Obes Rev. 2011;12(5):e472–93. 10.1111/j.1467-789X.2010.00785.x
   Google Scholar
• Nielsen TS, Bendiks Z, Thomsen B, Wright ME, Theil PK, Scherer BL, Marco ML. High-amylose maize, potato, and butyrylated starch modulate large intestinal fermentation, microbial composition, and oncogenic miRNA expression in rats fed a high-protein meat diet. Int J Mol Sci. 2019;20(9). 10.3390/ijms20092137
   Web of Science ®Google Scholar
• Fernández J, Ledesma E, Monte J, Millán E, Costa P, de la Fuente VG, García MTF, Martínez-Camblor P, Villar CJ, Lombó F, et al. Traditional processed meat products re-designed towards inulin-rich functional foods reduce polyps in two colorectal cancer animal models. Sci Rep. 2019;9(1):14783. 10.1038/s41598-019-51437-w
   PubMedGoogle Scholar
• Appunni S, Rubens M, Ramamoorthy V, Tonse R, Saxena A, McGranaghan P, Kaiser A, Kotecha R. Emerging evidence on the effects of dietary factors on the gut microbiome in colorectal cancer. Front Nutr. 2021;8:718389. 10.3389/fnut.2021.718389
   Web of Science ®Google Scholar
• Marlett JA, McBurney MI, Slavin JL, American Dietetic Association. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2002;102(7):993–1000. 10.1016/s0002-8223(02)90228-2
   PubMed Web of Science ®Google Scholar
• Anderson JW, Baird P, Davis RH, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL. Health benefits of dietary fiber. Nutr Rev. 2009;67(4):188–205. 10.1111/j.1753-4887.2009.00189.x
   PubMed Web of Science ®Google Scholar
• Speciani MC, Gargari G, Penagini R, Mutignani M, Ferraroni M, Natale A, Katsoulis M, Cintolo M, Leone P, Airoldi A, et al. Garlic consumption in relation to colorectal cancer risk and to alterations of blood bacterial DNA. Eur J Nutr. 2023;62(5):2279–92. 10.1007/s00394-023-03110-2
   Web of Science ®Google Scholar
• So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2018;107(6):965–83. 10.1093/ajcn/nqy041
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW, Greenwalt A, Ryan EP, et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014;4(12):1387–97. 10.1158/2159-8290.CD-14-0501
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger MK, Bultman SJ. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517–26. 10.1016/j.cmet.2011.02.018
   PubMed Web of Science ®Google Scholar
• Encarnação JC, Abrantes AM, Pires AS, Botelho MF. Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev. 2015; Sep34(3):465–78. 10.1007/s10555-015-9578-9
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569–73. 10.1126/science.1241165
   PubMed Web of Science ®Google Scholar
• Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40(1):128–39. 10.1016/j.immuni.2013.12.007
   PubMed Web of Science ®Google Scholar
• Tang Y, Chen Y, Jiang H, Robbins GT, Nie D. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer. 2011;128(4):847–56. 10.1002/ijc.25638
   PubMed Web of Science ®Google Scholar
• Song M, Chan AT. Diet, gut microbiota, and colorectal cancer prevention: a review of potential mechanisms and promising targets for future research. Curr Colorectal Cancer Rep. 2017; Dec13(6):429–39. 10.1007/s11888-017-0389-y
   Google Scholar
• Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Surendra A, Kumar S, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014;158(2):288–99. 10.1016/j.cell.2014.04.051
   PubMed Web of Science ®Google Scholar
• Clinton SK, Giovannucci EL, Hursting SD. The world cancer research fund/american institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr. 2020;150(4):663–71. 10.1093/jn/nxz268
   PubMed Web of Science ®Google Scholar
• Khan MT, Nieuwdorp M, Bäckhed F. Microbial modulation of insulin sensitivity. Cell Metab. 2014;20(5):753–60. 10.1016/j.cmet.2014.07.006
   PubMed Web of Science ®Google Scholar
• Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018;15(11):671–82. 10.1038/s41575-018-0025-6
   PubMed Web of Science ®Google Scholar
• Berg RD. Mechanisms in the Pathogenesis of Enteric Diseases 2. Springer, Boston, MA. 1999;473: p.11–30. doi:10.1007/978-1-4615-4143-1_2
   Google Scholar
• Xiao Q, Lu W, Kong X, Shao YW, Hu Y, Wang A, Bao H, Cao R, Liu K, Wang X, et al. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: a proof-of-concept study. Cancer Lett. 2021;499:201–8.
   PubMed Web of Science ®Google Scholar
• Shi M, Zong X, Hur J, Birmann BM, Martinez-Maza O, Epeldegui M, Chan AT, Giovannucci EL, Cao Y. Circulating markers of microbial translocation and host response to bacteria with risk of colorectal cancer: a prospective, nested case-control study in men. EBioMedicine. 2023;91:104566. 10.1016/j.ebiom.2023.104566
   PubMed Web of Science ®Google Scholar
• Horioka K, Tanaka H, Isozaki S, Konishi H, Fujiya M, Okuda K, Asari M, Shiono H, Ogawa K, Shimizu K, et al. Acute colchicine poisoning causes endotoxemia via the destruction of intestinal barrier function: the curative effect of endotoxin prevention in a murine model. Dig Dis Sci. 2020;65(1):132–40. 10.1007/s10620-019-05729-w
   PubMed Web of Science ®Google Scholar
• Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocr Soc. 2020;4(2):bvz039.
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–72. 10.2337/db06-1491
   PubMed Web of Science ®Google Scholar
• Yang B, Bostick RM, Tran HQ, Gewirtz AT, Campbell PT, Fedirko V. Circulating biomarkers of gut barrier function: correlates and nonresponse to calcium supplementation among colon adenoma patients. Cancer Epidemiol Biomarkers Prev. 2016;25(2):318–26. 10.1158/1055-9965.EPI-15-0488
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Frühbeck G, Burcelin R, et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond). 2012;36(11):1442–9. 10.1038/ijo.2011.256
   PubMed Web of Science ®Google Scholar
• Li R, Grimm SA, Mav D, Gu H, Djukovic D, Shah R, et al. Transcriptome and DNA methylome analysis in a mouse model of diet-induced obesity predicts increased risk of colorectal cancer. Cell Rep. 2018;22(3):624–37.
   PubMed Web of Science ®Google Scholar
• Li R, Grimm SA, Chrysovergis K, Kosak J, Wang X, Du Y, Burkholder A, Janardhan K, Mav D, Shah R, et al. Obesity, rather than diet, drives epigenomic alterations in colonic epithelium resembling cancer progression. Cell Metab. 2014;19(4):702–11. 10.1016/j.cmet.2014.03.012
   Web of Science ®Google Scholar
• Qin Y, Roberts JD, Grimm SA, Lih FB, Deterding LJ, Li R, Chrysovergis K, Wade PA. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression. Genome Biol. 2018;19(1):7. 10.1186/s13059-018-1389-1
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97–101. 10.1038/nature12347
   PubMed Web of Science ®Google Scholar
• Ohtani N, Yoshimoto S, Hara E. Obesity and cancer: a gut microbial connection. Cancer Res. 2014;74(7):1885–9. 10.1158/0008-5472.CAN-13-3501
   PubMed Web of Science ®Google Scholar
• Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, et al. Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity. Cancer Discov. 2017;7(5):522–38. 10.1158/2159-8290.CD-16-0932
   PubMed Web of Science ®Google Scholar
• Clarke SF, Murphy EF, O’Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O’Reilly M, Jeffery IB, Wood-Martin R, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913–20. 10.1136/gutjnl-2013-306541
   PubMed Web of Science ®Google Scholar
• Jang LG, Choi G, Kim SW, Kim BY, Lee S, Park H. The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study. J Int Soc Sports Nutr. 2019;16(1):21.
   Google Scholar
• Barton W, Penney NC, Cronin O, Garcia-Perez I, Molloy MG, Holmes E, Shanahan F, Cotter PD, O’Sullivan O. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut. 2018;67(4):625–33. 10.1136/gutjnl-2016-313627
   PubMed Web of Science ®Google Scholar
• Aya V, Flórez A, Perez L, Ramírez JD. Association between physical activity and changes in intestinal microbiota composition: A systematic review. PLoS One. 2021;16(2):e0247039. 10.1371/journal.pone.0247039
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Inoue R, Tsukahara T, Ushida K, Chiji H, Matsubara N, Hara H. Voluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecum. Biosci Biotechnol Biochem. 2008;72(2):572–6.
   PubMed Web of Science ®Google Scholar
• Evans CC, LePard KJ, Kwak JW, Stancukas MC, Laskowski S, Dougherty J, Moulton L, Glawe A, Wang Y, Leone V, et al. Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity. PLoS One. 2014;9(3):e92193. 10.1371/journal.pone.0092193
   PubMed Web of Science ®Google Scholar
• Petriz BA, Castro AP, Almeida JA, Gomes CP, Fernandes GR, Kruger RH, Pereira RW, Franco OL. Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats. BMC Genomics. 2014;15(1):511. 10.1186/1471-2164-15-511
   PubMed Web of Science ®Google Scholar
• McNabb S, Harrison TA, Albanes D, Berndt SI, Brenner H, Caan BJ, Campbell PT, Cao Y, Chang-Claude J, Chan A, et al. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer. 2020;146(3):861–73.
   PubMed Web of Science ®Google Scholar
• Tsuruya A, Kuwahara A, Saito Y, Yamaguchi H, Tenma N, Inai M, Takahashi S, Tsutsumi E, Suwa Y, Totsuka Y, et al. Major anaerobic bacteria responsible for the production of carcinogenic acetaldehyde from ethanol in the colon and rectum. Alcohol Alcohol. 2016;51(4):395–401. 10.1093/alcalc/agv135
   PubMed Web of Science ®Google Scholar
• Gong J, Hutter C, Baron JA, Berndt S, Caan B, Campbell PT, Casey G, Chan AT, Cotterchio M, Fuchs CS, et al. A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1974–85. 10.1158/1055-9965.EPI-12-0692
   Web of Science ®Google Scholar
• Lee SH, Yun Y, Kim SJ, Lee E-J, Chang Y, Ryu S, Shin H, Kim H-L, Kim H-N, Lee JH, et al. Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study. J Clin Med. 2018;7(9):282–94. 10.3390/jcm7090282
   PubMed Web of Science ®Google Scholar
• Gui X, Yang Z, Li MD. Effect of cigarette smoke on gut microbiota: state of knowledge. Front Physiol. 2021;12:673341. 10.3389/fphys.2021.673341
   PubMed Web of Science ®Google Scholar
• Berkowitz L, Pardo-Roa C, Salazar GA, Salazar-Echegarai F, Miranda JP, Ramírez G, Chávez JL, Kalergis AM, Bueno SM, Álvarez-Lobos M, et al. Mucosal exposure to cigarette components induces intestinal inflammation and alters antimicrobial response in mice. Front Immunol. 2019;10:2289. 10.3389/fimmu.2019.02289
   PubMed Web of Science ®Google Scholar
• Fluhr L, Mor U, Kolodziejczyk AA, Dori-Bachash M, Leshem A, Itav S, Cohen Y, Suez J, Zmora N, Moresi C, et al. Gut microbiota modulates weight gain in mice after discontinued smoke exposure. Nature. 2021;600(7890):713–9. 10.1038/s41586-021-04194-8
   Web of Science ®Google Scholar
• Biedermann L, Brülisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, Fried M, Loessner MJ, Rogler G, Schuppler M, et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis. 2014;20(9):1496–501.
   Web of Science ®Google Scholar
• Prakash A, Peters BA, Cobbs E, Beggs D, Choi H, Li H, Hayes RB, Ahn J. Tobacco Smoking and the Fecal Microbiome in a Large, Multi-ethnic Cohort. Cancer Epidemiol Biomarkers Prev. 2021; Jul30(7):1328–35. 10.1158/1055-9965.EPI-20-1417
   PubMed Web of Science ®Google Scholar
• Chi L, Bian X, Gao B, Tu P, Ru H, Lu K. The effects of an environmentally relevant level of arsenic on the gut microbiome and its functional metagenome. Toxicol Sci. 2017;160(2):193–204. 10.1093/toxsci/kfx174
   PubMed Web of Science ®Google Scholar
• Bai X, Wei H, Liu W, Coker OO, Gou H, Liu C, Zhao L, Li C, Zhou Y, Wang G, et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut. 2022;71(12):2439–50. 10.1136/gutjnl-2021-325021
   PubMed Web of Science ®Google Scholar
• Gomes SD, Oliveira CS, Azevedo-Silva J, Casanova MR, Barreto J, Pereira H, Chaves SR, Rodrigues LR, Casal M, Côrte-Real M, et al. The role of diet related short-chain fatty acids in colorectal cancer metabolism and survival: prevention and therapeutic implications. Curr Med Chem. 2020;27(24):4087–108. 10.2174/0929867325666180530102050
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhou Q, Dorfman RG, Huang X, Fan T, Zhang H, Zhang J, Yu C. Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol. 2016;16(1):84. 10.1186/s12876-016-0500-x
   PubMedGoogle Scholar
• Pan P, Oshima K, Huang YW, Agle KA, Drobyski WR, Chen X, et al. Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. Int J Cancer. 2018;143(4):886–96.
   Web of Science ®Google Scholar
• Lim SJ, Choi MK, Kim MJ, Lee CH. Effect of butyrate on the heregulin/ErbB-mediated proliferation of human colorectal cancer cells. Mol Med Rep. 2009;2(3):497–502. 10.3892/mmr_00000127
   Web of Science ®Google Scholar
• Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, Fosso B, Melocchi L, Nizzoli G, Troisi J, et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol. 2020;5(3):511–24. 10.1038/s41564-019-0649-5
   PubMed Web of Science ®Google Scholar
• Zeng H, Hamlin SK, Safratowich BD, Cheng WH, Johnson LK. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention. Nutr Res. 2020;83:63–72. 10.1016/j.nutres.2020.08.009
   PubMed Web of Science ®Google Scholar
• Carretta MD, Quiroga J, López R, Hidalgo MA, Burgos RA. Participation of short-chain fatty acids and their receptors in gut inflammation and colon cancer. Front Physiol. 2021;12:662739. 10.3389/fphys.2021.662739
   PubMed Web of Science ®Google Scholar
• Moniri NH, Farah Q. Short-chain free-fatty acid G protein-coupled receptors in colon cancer. Biochem Pharmacol. 2021;186:114483. 10.1016/j.bcp.2021.114483
   Web of Science ®Google Scholar
• Yu DCW, Waby JS, Chirakkal H, Staton CA, Corfe BM. Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer. 2010;9(1):276. 10.1186/1476-4598-9-276
   PubMedGoogle Scholar
• Yu DC, Bury JP, Tiernan J, Waby JS, Staton CA, Corfe BM. Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma. Mol Cancer. 2011;10(1):27. 10.1186/1476-4598-10-27
   Google Scholar
• Hu S, Liu L, Chang EB, Wang JY, Raufman JP. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Mol Cancer. 2015;14(1):180. 10.1186/s12943-015-0450-x
   PubMedGoogle Scholar
• Han R, Sun Q, Wu J, Zheng P, Zhao G. Sodium butyrate upregulates miR-203 expression to exert anti-proliferation effect on colorectal cancer cells. Cell Physiol Biochem. 2016;39(5):1919–29. 10.1159/000447889
   PubMedGoogle Scholar
• Li Q, Ding C, Meng T, Lu W, Liu W, Hao H, et al. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner. J Pharmacol Sci. 2017;135(4):148–55.
   PubMed Web of Science ®Google Scholar
• Alrafas HRD, Busbee BP, Nagarkatti P, Nagarkatti M. Effect of sodium butyrate supplementation on the gut microbiome during colorectal cancer. J Immunol. 2019;202(1_Suppl):191.10. 10.4049/jimmunol.202.Supp.191.10
   Web of Science ®Google Scholar
• Luu M, Weigand K, Wedi F, Breidenbend C, Leister H, Pautz S, Adhikary T, Visekruna A. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Sci Rep. 2018;8(1):14430. 10.1038/s41598-018-32860-x
   PubMedGoogle Scholar
• Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol. 2007;13(20):2826–32.
   PubMed Web of Science ®Google Scholar
• Liu Z, Cao AT, Cong Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol. 2013;23(6 Pt B):543–52. 10.1016/j.semcancer.2013.09.002
   Web of Science ®Google Scholar
• Jalandra R, Dalal N, Yadav AK, Verma D, Sharma M, Singh R, Khosla A, Kumar A, Solanki PR. Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer. Appl Microbiol Biotechnol. 2021;105(20):7651–60. 10.1007/s00253-021-11582-7
   PubMed Web of Science ®Google Scholar
• Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng T-YD, et al. Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study. Cancer Res. 2014;74(24):7442–52. 10.1158/0008-5472.CAN-14-1835
   PubMed Web of Science ®Google Scholar
• Liu X, Liu H, Yuan C, Zhang Y, Wang W, Hu S, Liu L, Wang Y. Preoperative serum TMAO level is a new prognostic marker for colorectal cancer. Biomark Med. 2017;11(5):443–7. 10.2217/bmm-2016-0262
   PubMed Web of Science ®Google Scholar
• Xu R, Wang Q, Li L. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics. 2015;16 Suppl 7(Suppl 7):S4. 10.1186/1471-2164-16-S7-S4
   Google Scholar
• Yang S, Dai H, Lu Y, Li R, Gao C, Pan S. Trimethylamine N-Oxide promotes cell proliferation and angiogenesis in colorectal cancer. J Immunol Res. 2022;2022:7043856–7. 10.1155/2022/7043856
   PubMed Web of Science ®Google Scholar
• Chan CWH, Law BMH, Waye MMY, Chan JYW, So WKW, Chow KM. Trimethylamine-N-oxide as one hypothetical link for the relationship between intestinal microbiota and cancer - where we are and where shall we go? J Cancer. 2019;10(23):5874–82.
   PubMed Web of Science ®Google Scholar
• Oellgaard J, Winther SA, Hansen TS, Rossing P, von Scholten BJ. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer. Curr Pharm Des. 2017;23(25):3699–712. 10.2174/1381612823666170622095324
   PubMed Web of Science ®Google Scholar
• Robbiano L, Mereto E, Corbu C, Brambilla G. DNA damage induced by seven N-nitroso compounds in primary cultures of human and rat kidney cells. Mutat Res. 1996;368(1):41–7. 10.1016/s0165-1218(96)90038-5
   Google Scholar
• Kushkevych I, Cejnar J, Treml J, Dordević D, Kollar P, Vítězová M. Recent advances in metabolic pathways of sulfate reduction in intestinal bacteria. Cells. 2020;9(3):698. 10.3390/cells9030698
   PubMed Web of Science ®Google Scholar
• Zhang W, An Y, Qin X, Wu X, Wang X, Hou H, Song X, Liu T, Wang B, Huang X, et al. Gut microbiota-derived metabolites in colorectal cancer: the bad and the challenges. Front Oncol. 2021;11:739648. 10.3389/fonc.2021.739648
   Web of Science ®Google Scholar
• Kushkevych I, Dordević D, Vítězová M. Possible synergy effect of hydrogen sulfide and acetate produced by sulfate-reducing bacteria on inflammatory bowel disease development. J Adv Res. 2021;27:71–8. 10.1016/j.jare.2020.03.007
   PubMed Web of Science ®Google Scholar
• Rey FE, Gonzalez MD, Cheng J, Wu M, Ahern PP, Gordon JI. Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc Natl Acad Sci USA. 2013;110(33):13582–7. 10.1073/pnas.1312524110
   PubMed Web of Science ®Google Scholar
• Gibson GR, Macfarlane GT, Cummings JH. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol. 1988;65(2):103–11. 10.1111/j.1365-2672.1988.tb01498.x
   PubMedGoogle Scholar
• Blachier F, Beaumont M, Kim E. Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin. Curr Opin Clin Nutr Metab Care. 2019;22(1):68–75. 10.1097/MCO.0000000000000526
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Ma W, Wang DD, Cao Y, Mallick H, Gerbaba TK, Lloyd-Price J, Abu-Ali G, Hall AB, Sikavi D, et al. Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men. Gastroenterology. 2020;158(5):1313–25. 10.1053/j.gastro.2019.12.029
   PubMed Web of Science ®Google Scholar
• Wang RH, Chu YH, Lin KT. The hidden role of hydrogen sulfide metabolism in cancer. Int J Mol Sci. 2021;22(12):6562. 10.3390/ijms22126562
   PubMed Web of Science ®Google Scholar
• Shackelford RE, Mohammad IZ, Meram AT, Kim D, Alotaibi F, Patel S, Ghali GE, Kevil CG. Molecular functions of hydrogen sulfide in cancer. Pathophysiology. 2021;28(3):437–56. 10.3390/pathophysiology28030028
   Google Scholar
• Khattak S, Rauf MA, Khan NH, Zhang Q-Q, Chen H-J, Muhammad P, Ansari MA, Alomary MN, Jahangir M, Zhang C-Y, et al. Hydrogen sulfide biology and its role in cancer. Molecules. 2022;27(11):3389. 10.3390/molecules27113389
   Web of Science ®Google Scholar
• Beaumont M, Andriamihaja M, Lan A, Khodorova N, Audebert M, Blouin J-M, Grauso M, Lancha L, Benetti P-H, Benamouzig R, et al. Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: the adaptive response. Free Radic Biol Med. 2016;93:155–64. 10.1016/j.freeradbiomed.2016.01.028
   PubMed Web of Science ®Google Scholar
• Libiad M, Vitvitsky V, Bostelaar T, Bak DW, Lee H-J, Sakamoto N, Fearon E, Lyssiotis CA, Weerapana E, Banerjee R, et al. Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells. J Biol Chem. 2019;294(32):12077–90. 10.1074/jbc.RA119.009442
   PubMed Web of Science ®Google Scholar
• Sakuma S, Minamino S, Takase M, Ishiyama Y, Hosokura H, Kohda T, Ikeda Y, Fujimoto Y. Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death. Heliyon. 2019;5(8):e02244. 10.1016/j.heliyon.2019.e02244
   PubMed Web of Science ®Google Scholar
• Vitvitsky V, Libiad M, Bostelaar T, Maebius A, Lee H, Lyssiotis CA, Banerjee R. Reprogramming of colonic cell metabolism by H 2 S. FASEB J. 2019;33(S1):485–511. 10.1096/fasebj.2019.33.1_supplement.485.11
   Google Scholar
• Du P, Tseng Y, Liu P, Zhang H, Huang G, Hu C, Chen J. Role of exhaled hydrogen sulfide in the diagnosis of colorectal cancer. BMJ Open Gastroenterol. 2024;11(1):e001229. 10.1136/bmjgast-2023-001229
   Web of Science ®Google Scholar
• Wang Y, Nguyen LH, Mehta RS, Song M, Huttenhower C, Chan AT. Association between the sulfur microbial diet and risk of colorectal cancer. JAMA Netw Open. 2021;4(11):e2134308. 10.1001/jamanetworkopen.2021.34308
   Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111–28. 10.1038/nrgastro.2017.119
   PubMed Web of Science ®Google Scholar
• Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int J Mol Sci. 2019;20(5).
   Web of Science ®Google Scholar
• Wise JL, Cummings BP. The 7-α-dehydroxylation pathway: an integral component of gut bacterial bile acid metabolism and potential therapeutic target. Front Microbiol. 2022;13:1093420. 10.3389/fmicb.2022.1093420
   Web of Science ®Google Scholar
• Liu T, Song X, Khan S, Li Y, Guo Z, Li C, Wang S, Dong W, Liu W, Wang B, et al. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: an old story, yet mesmerizing. Int J Cancer. 2020;146(7):1780–90.
   Web of Science ®Google Scholar
• Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011;85(8):863–71. 10.1007/s00204-011-0648-7
   PubMed Web of Science ®Google Scholar
• Turjman N, Goodman GT, Jaeger B, Nair PP. Metabolism of bile acids. Am J Clin Nutr. 1984;40(4 Suppl):937–41. 10.1093/ajcn/40.4.937
   Google Scholar
• Ignacio Barrasa J, Olmo N, Pérez-Ramos P, Santiago-Gómez A, Lecona E, Turnay J, Antonia Lizarbe M. Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells. Apoptosis. 2011;16(10):1054–67. 10.1007/s10495-011-0633-x
   Web of Science ®Google Scholar
• Ward JBJ, Lajczak NK, Kelly OB, O’Dwyer AM, Giddam AK, Ní Gabhann J, et al. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am J Physiol Gastrointest Liver Physiol. 2017;312(6):G550–8.
   PubMed Web of Science ®Google Scholar
• Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VAC, Harrison ME, McCashland T, Befeler AS, Harnois D, et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol. 2011;106(9):1638–45. 10.1038/ajg.2011.156
   PubMed Web of Science ®Google Scholar
• Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis. 2022;13(4):1106–26. 10.14336/AD.2022.0104
   PubMed Web of Science ®Google Scholar
• Imdad S, Lim W, Kim JH, Kang C. Intertwined relationship of mitochondrial metabolism, gut microbiome and exercise potential. Int J Mol Sci. 2022;23(5):2679.
   Web of Science ®Google Scholar
• Cao Y, Aquino-Martinez R, Hutchison E, Allayee H, Lusis AJ, Rey FE. Role of gut microbe-derived metabolites in cardiometabolic diseases: systems based approach. Mol Metab. 2022; Oct64:101557. 10.1016/j.molmet.2022.101557
   Web of Science ®Google Scholar
• Buret AG, Allain T, Motta JP, Wallace JL. Effects of hydrogen sulfide on the microbiome: from toxicity to therapy. Antioxid Redox Signal. 2022;36(4–6):211–9. 10.1089/ars.2021.0004
   PubMed Web of Science ®Google Scholar
• Yang R, Qian L. Research on gut microbiota-derived secondary bile acids in cancer progression. Integr Cancer Ther. 2022;21:15347354221114100. 10.1177/15347354221114100
   Web of Science ®Google Scholar
• Perillo F, Amoroso C, Strati F, Giuffrè MR, Díaz-Basabe A, Lattanzi G, Facciotti F. Gut microbiota manipulation as a tool for colorectal cancer management: recent advances in its use for therapeutic purposes. Int J Mol Sci. 2020;21(15)
   Web of Science ®Google Scholar
• Yang J, McDowell A, Kim EK, Seo H, Lee WH, Moon C-M, Kym S-M, Lee DH, Park YS, Jee Y-K, et al. Development of a colorectal cancer diagnostic model and dietary risk assessment through gut microbiome analysis. Exp Mol Med. 2019;51(10):1–15. 10.1038/s12276-019-0313-4
   Google Scholar
• Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM, Maggio-Price L. Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res. 2014;74(16):4398–408. 10.1158/0008-5472.CAN-13-2820
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen C, Zhong YN, Zhao F, Hao Z, Xu Y, Lai R, Shen G, Yin X. Effect and mechanism of vitamin D on the development of colorectal cancer based on intestinal flora disorder. J Gastroenterol Hepatol. 2020;35(6):1023–31.
   Web of Science ®Google Scholar
• Brandhorst S, Longo VD. Fasting and caloric restriction in cancer prevention and treatment. Recent Results Cancer Res. 2016;207:241–66. 10.1007/978-3-319-42118-6_12
   Google Scholar
• Li G, Xie C, Lu S, Nichols RG, Tian Y, Li L, Patel D, Ma Y, Brocker CN, Yan T, et al. Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota. Cell Metab. 2017;26(4):672–85.e4. 10.1016/j.cmet.2017.08.019
   PubMed Web of Science ®Google Scholar
• Zheng X, Zhou K, Zhang Y, Han X, Zhao A, Liu J, Qu C, Ge K, Huang F, Hernandez B, et al. Food withdrawal alters the gut microbiota and metabolome in mice. FASEB J. 2018;32(9):4878–88. 10.1096/fj.201700614R
   Web of Science ®Google Scholar
• Hao GW, Chen YS, He DM, Wang HY, Wu GH, Zhang B. Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides. Asian Pac J Cancer Prev. 2015;16(5):2061–8. 10.7314/apjcp.2015.16.5.2061
   PubMedGoogle Scholar
• Cao H, Xu M, Dong W, Deng B, Wang S, Zhang Y, Wang S, Luo S, Wang W, Qi Y, et al. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int J Cancer. 2017;140(11):2545–56.
   PubMed Web of Science ®Google Scholar
• Zackular JP, Baxter NT, Chen GY, Schloss PD. Manipulation of the gut microbiota reveals role in colon tumorigenesis. mSphere. 2016;1(1):e00001-15. 10.1128/mSphere.00001-15
   Web of Science ®Google Scholar
• Wang M, Li Y, Yang X, Liu Z, Wang K, Gong D, Li J. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice. Immun Inflamm Dis. 2023; Nov11(11):e1067.
   Web of Science ®Google Scholar
• Triner D, Devenport SN, Ramakrishnan SK, Ma X, Frieler RA, Greenson JK, Inohara N, Nunez G, Colacino JA, Mortensen RM, et al. Neutrophils restrict tumor-associated microbiota to reduce growth and invasion of colon tumors in mice. Gastroenterology. 2019;156(5):1467–82. 10.1053/j.gastro.2018.12.003
   PubMed Web of Science ®Google Scholar
• Yu Y-N, Yu T-C, Zhao H-J, Sun T-T, Chen H-M, Chen H-Y, An H-F, Weng Y-R, Yu J, Li M, et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget. 2015;6(31):32013–26. 10.18632/oncotarget.5166
   PubMedGoogle Scholar
• DeStefano Shields CE, Van Meerbeke SW, Housseau F, Wang H, Huso DL, Casero RA, O’Hagan HM, Sears CL. Reduction of murine colon tumorigenesis driven by enterotoxigenic bacteroides fragilis using cefoxitin treatment. J Infect Dis. 2016;214(1):122–9. 10.1093/infdis/jiw069
   Web of Science ®Google Scholar
• Hamoya T, Miyamoto S, Tomono S, Fujii G, Nakanishi R, Komiya M, Tamura S, Fujimoto K, Toshima J, Wakabayashi K, et al. Chemopreventive effects of a low-side-effect antibiotic drug, erythromycin, on mouse intestinal tumors. J Clin Biochem Nutr. 2017;60(3):199–207. 10.3164/jcbn.16-107
   Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–14. 10.1038/nrgastro.2014.66
   PubMed Web of Science ®Google Scholar
• Vitetta L, Vitetta G, Hall S. Immunological tolerance and function: associations between intestinal bacteria, probiotics, prebiotics, and phages. Front Immunol. 2018;9:2240. 10.3389/fimmu.2018.02240
   PubMed Web of Science ®Google Scholar
• Gamallat Y, Meyiah A, Kuugbee ED, Hago AM, Chiwala G, Awadasseid A, Bamba D, Zhang X, Shang X, Luo F, et al. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother. 2016;83:536–41. 10.1016/j.biopha.2016.07.001
   PubMed Web of Science ®Google Scholar
• Gamallat Y, Ren X, Walana W, Meyiah A, Xinxiu R, Zhu Y, et al. Probiotic Lactobacillus rhamnosus modulates the gut microbiome composition attenuates preneoplastic colorectal Aberrant crypt foci. J Funct Foods. 2019;53:146–56.
   Web of Science ®Google Scholar
• Jacouton E, Chain F, Sokol H, Langella P, Bermúdez-Humarán LG. Probiotic strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer. Front Immunol. 2017;8:1553. 10.3389/fimmu.2017.01553
   PubMed Web of Science ®Google Scholar
• Chen D, Jin D, Huang S, Wu J, Xu M, Liu T, Dong W, Liu X, Wang S, Zhong W, et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020;469:456–67.
   PubMed Web of Science ®Google Scholar
• Cousin FJ, Jouan-Lanhouet S, Théret N, Brenner C, Jouan E, Le Moigne-Muller G, Dimanche-Boitrel M-T, Jan G. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer. Oncotarget. 2016;7(6):7161–78. 10.18632/oncotarget.6881
   PubMedGoogle Scholar
• De Marco S, Sichetti M, Muradyan D, Piccioni M, Traina G, Pagiotti R, Pietrella D. Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS. Evid Based Complement Alternat Med. 2018;2018:1756308–12. 10.1155/2018/1756308
   Web of Science ®Google Scholar
• Nozari S, Faridvand Y, Etesami A, Ahmad Khan Beiki M, Miresmaeili Mazrakhondi SA, Abdolalizadeh J. Potential anticancer effects of cell wall protein fractions from Lactobacillus paracasei on human intestinal Caco-2 cell line. Lett Appl Microbiol. 2019;69(3):148–54. 10.1111/lam.13198
   PubMed Web of Science ®Google Scholar
• Fortin O, Aguilar-Uscanga BR, Vu KD, Salmieri S, Lacroix M. Effect of Saccharomyces boulardii cell wall extracts on colon cancer prevention in male F344 rats treated with 1,2-dimethylhydrazine. Nutr Cancer. 2018;70(4):632–42. 10.1080/01635581.2018.1460672
   PubMed Web of Science ®Google Scholar
• Chen ZY, Hsieh YM, Huang CC, Tsai CC. Inhibitory effects of Probiotic lactobacillus on the growth of human colonic carcinoma cell line HT-29. Molecules. 2017;22(1):107–18. 10.3390/molecules22010107
   PubMed Web of Science ®Google Scholar
• Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S. Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Appl Microbiol Biotechnol. 2017;101(5):1999–2019. 10.1007/s00253-016-7885-x
   PubMed Web of Science ®Google Scholar
• Sambrani R, Abdolalizadeh J, Kohan L, Jafari B. Saccharomyces cerevisiae inhibits growth and metastasis and stimulates apoptosis in HT-29 colorectal cancer cell line. Comp Clin Path. 2019;28(4):985–95.
   Google Scholar
• Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R, Sharma J, Karmakar S. Exploring the role of gut microbiome in colon cancer. Appl Biochem Biotechnol. 2021;193(6):1780–99. 10.1007/s12010-021-03498-9
   PubMed Web of Science ®Google Scholar
• Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O’Riordan M, O’Sullivan GC, Pool-Zobel B, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007;85(2):488–96. 10.1093/ajcn/85.2.488
   PubMed Web of Science ®Google Scholar
• Pineiro M, Asp N-G, Reid G, Macfarlane S, Morelli L, Brunser O, Tuohy K. FAO Technical meeting on prebiotics. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 2(Suppl 3):S156–S9. 10.1097/MCG.0b013e31817f184e
   Google Scholar
• Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502. 10.1038/nrgastro.2017.75
   PubMed Web of Science ®Google Scholar
• Bach Knudsen KE. Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health. Adv Nutr. 2015;6(2):206–13. 10.3945/an.114.007450
   Web of Science ®Google Scholar
• Kotecha R, Takami A, Espinoza JL. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget. 2016;7(32):52517–29. 10.18632/oncotarget.9593
   PubMedGoogle Scholar
• Hosseini A, Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed. 2015;5(2):84–97.
   PubMed Web of Science ®Google Scholar
• Annison G, Illman RJ, Topping DL. Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J Nutr. 2003;133(11):3523–8. 10.1093/jn/133.11.3523
   Web of Science ®Google Scholar
• Patterson JA, Burkholder KM. Application of prebiotics and probiotics in poultry production. Poult Sci. 2003;82(4):627–31. 10.1093/ps/82.4.627
   PubMed Web of Science ®Google Scholar
• Baurhoo B, Letellier A, Zhao X, Ruiz-Feria CA. Cecal populations of lactobacilli and bifidobacteria and Escherichia coli populations after in vivo Escherichia coli challenge in birds fed diets with purified lignin or mannanoligosaccharides. Poult Sci. 2007;86(12):2509–16. 10.3382/ps.2007-00136
   PubMed Web of Science ®Google Scholar
• Xie X, He Y, Li H, Yu D, Na L, Sun T, Zhang D, Shi X, Xia Y, Jiang T, et al. Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients. Nutrition. 2019;61:132–42. 10.1016/j.nut.2018.10.038
   PubMed Web of Science ®Google Scholar
• Fidelis M, Santos JS, Escher GB, Rocha RS, Cruz AG, Cruz TM, Marques MB, Nunes JB, do Carmo MAV, de Almeida LA, et al. Polyphenols of jabuticaba [Myrciaria jaboticaba (Vell.) O.Berg] seeds incorporated in a yogurt model exert antioxidant activity and modulate gut microbiota of 1,2-dimethylhydrazine-induced colon cancer in rats. Food Chem. 2021;334:127565. 10.1016/j.foodchem.2020.127565
   Web of Science ®Google Scholar
• Pabst O. New concepts in the generation and functions of IgA. Nat Rev Immunol. 2012;12(12):821–32. 10.1038/nri3322
   PubMed Web of Science ®Google Scholar
• Kumari R, Kumar S, Ahmad MK, Singh R, Pradhan A, Chandra S, Kumar S. TNF-α/IL-10 ratio: an independent predictor for coronary artery disease in North Indian population. Diabetes Metab Syndr. 2018;12(3):221–5. 10.1016/j.dsx.2017.09.006
   PubMed Web of Science ®Google Scholar
• Gorosito Serrán M, Fiocca Vernengo F, Beccaria CG, Acosta Rodriguez EV, Montes CL, Gruppi A. The regulatory role of B cells in autoimmunity, infections and cancer: perspectives beyond IL10 production. FEBS Lett. 2015;589(22):3362–9. 10.1016/j.febslet.2015.08.048
   Web of Science ®Google Scholar
• Verediano TA, Viana ML, das Graças Vaz Tostes M, de Oliveira DS, de Carvalho Nunes L, Costa NM. Yacón (Smallanthus sonchifolius) prevented inflammation, oxidative stress, and intestinal alterations in an animal model of colorectal carcinogenesis. J Sci Food Agric. 2020;100(15):5442–9. 10.1002/jsfa.10595
   PubMed Web of Science ®Google Scholar
• Hrncir T. Gut microbiota dysbiosis: triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10(3):578. 10.3390/microorganisms10030578
   PubMed Web of Science ®Google Scholar
• Brandt LJ, Borody TJ, Campbell J. Endoscopic fecal microbiota transplantation: “first-line” treatment for severe clostridium difficile infection? J Clin Gastroenterol. 2011;45(8):655–7. 10.1097/MCG.0b013e3182257d4f
   PubMed Web of Science ®Google Scholar
• Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol. 2020;13(3):637–56. 10.1111/1751-7915.13524
   PubMed Web of Science ®Google Scholar
• Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22(7):713–22. 10.1038/nm.4142
   PubMed Web of Science ®Google Scholar
• Mutalub YB, Abdulwahab M, Mohammed A, Yahkub AM, Al-Mhanna SB, Yusof W, Tang SP, Rasool AHG, Mokhtar SS. Gut microbiota modulation as a novel therapeutic strategy in cardiometabolic diseases. Foods. 2022;11(17):2575. 10.3390/foods11172575
   Web of Science ®Google Scholar
• Cui J, Lin Z, Tian H, Yang B, Zhao D, Ye C, Li N, Qin H, Chen Q. Long-Term follow-up results of fecal microbiota transplantation for irritable bowel syndrome: a single-center, retrospective study. Front Med (Lausanne). 2021;8:710452. 10.3389/fmed.2021.710452
   Web of Science ®Google Scholar
• Lopetuso LR, Ianiro G, Allegretti JR, Bibbò S, Gasbarrini A, Scaldaferri F, Cammarota G. Fecal transplantation for ulcerative colitis: current evidence and future applications. Expert Opin Biol Ther. 2020;20(4):343–51. 10.1080/14712598.2020.1733964
   PubMed Web of Science ®Google Scholar
• Tian H, Ge X, Nie Y, Yang L, Ding C, McFarland LV, Zhang X, Chen Q, Gong J, Li N, et al. Fecal microbiota transplantation in patients with slow-transit constipation: a randomized, clinical trial. PLoS One. 2017;12(2):e0171308. 10.1371/journal.pone.0171308
   PubMed Web of Science ®Google Scholar
• Xue L-J, Yang X-Z, Tong Q, Shen P, Ma S-J, Wu S-N, Zheng J-L, Wang H-G. Fecal microbiota transplantation therapy for Parkinson’s disease: a preliminary study. Medicine. 2020;99(35):e22035. 10.1097/MD.0000000000022035
   Web of Science ®Google Scholar
• Wang Z, Hua W, Li C, Chang H, Liu R, Ni Y, Sun H, Li Y, Wang X, Hou M, et al. Protective role of fecal microbiota transplantation on colitis and colitis-associated colon cancer in mice is associated with treg cells. Front Microbiol. 2019;10:2498. 10.3389/fmicb.2019.02498
   PubMed Web of Science ®Google Scholar
• Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, Hickman HD, McCulloch JA, Badger JH, Ajami NJ, et al. Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell. 2017;171(5):1015–28.e13. 10.1016/j.cell.2017.09.016
   PubMed Web of Science ®Google Scholar